SynopsisLive, orally administered, attenuated vaccine strains of Vibrio cholerae have many theoretical advantages over killed vaccines. The global Cholera Vaccines Oral Live market size is expected to reach US$ 143.7 million by 2029, growing at a CAGR of 7.0% fr.....
SynopsisLive, orally administered, attenuated vaccine strains of Vibrio cholerae have many theoretical advantages over killed vaccines. The global Oral Live Cholera Vaccines market size is expected to reach US$ 143.7 million by 2029, growing at a CAGR of 7.0% fr.....
SynopsisThe drug decreases the absorption of cholesterol and is used to dissolve (cholesterol) gallstones in patients as an alternative to a surgical procedure to remove the gallstones. The global Drugs of Ursodeoxycholic Acid market size is expected to reach US.....
SynopsisThe drug decreases the absorption of cholesterol and is used to dissolve (cholesterol) gallstones in patients as an alternative to a surgical procedure to remove the gallstones. The global Drugs of UDCA market size is expected to reach US$ 3389.8 million.....
SynopsisDrugs used as treatments for asthma and COPD The global Drugs for Asthma and COPD market size is expected to reach US$ 68020 million by 2029, growing at a CAGR of 5.8% from 2023 to 2029. The market is mainly driven by the significant applications of Drug.....
SynopsisPolymyxins are antibiotics. Polymyxins B and E (also known as colistin) are used in the treatment of Gram-negative bacterial infections. The global Polymixin B market size is expected to reach US$ 52 million by 2029, growing at a CAGR of -2.1% from 2023.....
SynopsisCefaclor, sold under the trade name Ceclor among others, is a second-generation cephalosporin antibiotic used to treat certain bacterial infections such as pneumonia and infections of the ear, lung, skin, throat, and urinary tract. The global Cefaclor ma.....
SynopsisCefradine is a first generation cephalosporin antibiotic. The global Cephradine market size is expected to reach US$ 505.5 million by 2029, growing at a CAGR of 2.3% from 2023 to 2029. The market is mainly driven by the significant applications of Cephra.....
SynopsisCefadroxil (formerly trademarked as Duricef) is a broad-spectrum antibiotic of the cephalosporin type, effective in Gram-positive and Gram-negative bacterial The global Cefadroxil market size is expected to reach US$ 354.3 million by 2029, growing at a C.....
SynopsisCephalexin is a cephalosporin (SEF a low spor in) antibiotic. It works by fighting bacteria in your body. The global Cephalexine market size is expected to reach US$ 205.4 million by 2029, growing at a CAGR of 2.9% from 2023 to 2029. The market is mainl.....
